Article
Metabolic Dysregulations and Epigenetics: A Bidirectional Interplay that Drives Tumor Progression
30 Jul 2019
Abstract excerpt
Cancer has been considered, for a long time, a genetic disease where mutations in keyregulatory genes drive tumor initiation, growth, metastasis, and drug resistance. Instead, theadvent of high-throughput technologies has revolutionized cancer research, allowing to investigatemolecular alterations at multiple levels, including genome, epigenome, transcriptome, proteome,and metabolome and showing the multifaceted...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
